Harpoon Therapeutics (HARP) Short Interest Ratio & Short Volume → The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free HARP Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaSustainability Harpoon Therapeutics Short Interest DataCurrent Short Volume538,400 sharesPrevious Short Volume1,160,000 sharesChange Vs. Previous Month-53.59%Dollar Volume Sold Short$12.35 millionShort Interest Ratio / Days to Cover0.5Last Record DateFebruary 29, 2024Outstanding Shares16,932,000 sharesFloat Size12,500,000 sharesShort Percent of Float4.31%Today's Trading Volume0 sharesAverage Trading Volume1,516,200 sharesToday's Volume Vs. Average0% Short Selling Harpoon Therapeutics ? Sign up to receive the latest short interest report for Harpoon Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatHARP Short Interest Over TimeHARP Days to Cover Over TimeHARP Percentage of Float Shorted Over Time Ad Weiss RatingsThe ONE AI Stock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now. Harpoon Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/29/2024538,400 shares $12.35 million -53.6%4.3%0.5 $22.94 2/15/20241,160,000 shares $26.02 million +111.8%11.7%1.2 $22.43 1/31/2024547,700 shares $12.23 million +15.2%5.5%0.8 $22.33 1/15/2024475,400 shares $10.65 million -43.5%4.1%0.9 $22.40 12/31/2023841,300 shares $9.57 million +75.4%7.1%2 $11.37 12/15/2023479,700 shares $4.87 million +21.2%4.1%2.3 $10.16 Get the Latest News and Ratings for HARP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Harpoon Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/30/2023395,800 shares $4.20 million +55.0%3.4%2.2 $10.60 11/15/2023255,300 shares $2.22 million +7.2%1.9%1.6 $8.69 10/31/2023238,200 shares $1.20 million +400.4%45.3%2 $5.04 10/15/202347,600 shares $198,492.00 +7.0%1.8%0.5 $4.17 9/30/202344,500 shares $179,335.00 +61.8%1.7%1.2 $4.03 9/15/202327,500 shares $138,875.00 -25.5%1.0%0.8 $5.05 8/31/202336,900 shares $383,760.00 -63.9%1.4%1.3 $10.40 8/15/2023102,100 shares $82,496.80 -34.8%0.4%0.5 $0.81 7/31/2023156,700 shares $122,743.11 +16.8%0.6%0.8 $0.78 7/15/2023134,200 shares $103,334.00 -71.7%0.5%0.7 $0.77 6/30/2023473,300 shares $336,043.00 +10.4%1.9%2.3 $0.71 6/15/2023428,600 shares $318,921.26 +51.5%1.7%2.1 $0.74 5/31/2023283,000 shares $192,440.00 -32.3%1.1%1.3 $0.68 5/15/2023417,700 shares $313,776.24 -45.1%1.7%1.8 $0.75 4/30/2023761,200 shares $445,378.12 +115.5%3.3%2.5 $0.59 4/15/2023353,200 shares $248,299.60 -4.5%1.5%0.9 $0.70 3/31/2023370,000 shares $275,354.00 -4.6%1.7%0.9 $0.74 3/15/2023387,700 shares $294,652.00 +60.6%2.0%0.8 $0.76 2/28/2023241,400 shares $186,940.16 +32.6%1.3%0.1 $0.77 2/15/2023182,000 shares $147,420.00 -53.6%1.0%0.1 $0.81 1/31/2023392,100 shares $423,468.00 +112.6%2.0%0.2 $1.08 1/15/2023184,400 shares $153,420.80 -80.2%1.0%0.1 $0.83 12/30/2022932,300 shares $676,570.11 -21.7%5.2%0.5 $0.73 12/15/20221,190,000 shares $858,347.00 +111.3%6.7%0.6 $0.72 11/30/2022563,100 shares $385,779.81 +15.1%3.2%3.3 $0.69 11/15/2022489,300 shares $398,094.48 +21.0%2.8%3.1 $0.81 10/31/2022404,400 shares $369,540.72 +0.3%2.3%2.6 $0.91 10/15/2022403,300 shares $399,831.62 +3.9%2.3%2.6 $0.99 9/30/2022388,000 shares $376,398.80 -9.3%2.2%2.4 $0.97 9/15/2022427,800 shares $693,036.00 +3.0%2.4%2.3 $1.62 8/31/2022415,400 shares $689,564.00 -6.2%2.4%2.5 $1.66 8/15/2022442,900 shares $947,806.00 -14.9%2.5%2.2 $2.14 7/31/2022520,700 shares $1.02 million -7.8%3.0%2.2 $1.95 7/15/2022564,700 shares $1.42 million -7.0%3.2%2.3 $2.52Things Are Not Normal in America – Here’s What to Do (Ad)Get Out of the Dollar Before May 15 A Wall Street legend and our friend has just warned 896,000 Americans to prepare for May 15.This could be your solution. HARP Short Interest - Frequently Asked Questions What is Harpoon Therapeutics' current short interest? Short interest is the volume of Harpoon Therapeutics shares that have been sold short but have not yet been closed out or covered. As of February 29th, traders have sold 538,400 shares of HARP short. 4.31% of Harpoon Therapeutics' shares are currently sold short. Learn More on Harpoon Therapeutics' current short interest. What is a good short interest percentage for Harpoon Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.31% of Harpoon Therapeutics' floating shares are currently sold short. Is Harpoon Therapeutics' short interest increasing or decreasing? Harpoon Therapeutics saw a decrease in short interest during the month of February. As of February 29th, there was short interest totaling 538,400 shares, a decrease of 53.6% from the previous total of 1,160,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Harpoon Therapeutics' float size? Harpoon Therapeutics currently has issued a total of 16,932,000 shares. Some of Harpoon Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Harpoon Therapeutics currently has a public float of 12,500,000 shares. How does Harpoon Therapeutics' short interest compare to its competitors? 4.31% of Harpoon Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Harpoon Therapeutics: Harrow, Inc. (16.73%), Solid Biosciences Inc. (3.47%), NeuroPace, Inc. (0.72%), ADC Therapeutics SA (1.60%), Health Catalyst, Inc. (2.98%), Amarin Co. plc (3.86%), Black Diamond Therapeutics, Inc. (3.35%), Erasca, Inc. (10.56%), Mereo BioPharma Group plc (2.22%), Ocugen, Inc. (17.58%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.39 billion), General Motors ($3.88 billion), Super Micro Computer, Inc. ($3.51 billion), Charter Communications, Inc. ($3.22 billion), Occidental Petroleum Co. ($3.13 billion), Tractor Supply ($2.76 billion), Coinbase Global, Inc. ($2.63 billion), Suncor Energy Inc. ($2.48 billion), Moderna, Inc. ($2.04 billion), and Royal Caribbean Cruises Ltd. ($1.87 billion). View all of the most shorted stocks. What does it mean to sell short Harpoon Therapeutics stock? Short selling HARP is an investing strategy that aims to generate trading profit from Harpoon Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Harpoon Therapeutics? A short squeeze for Harpoon Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HARP, which in turn drives the price of the stock up even further. How often is Harpoon Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HARP, twice per month. The most recent reporting period available is February, 29 2024. More Short Interest Resources from MarketBeat Related Companies: Harrow Short Interest Solid Biosciences Short Interest NeuroPace Short Interest ADC Therapeutics Short Interest Health Catalyst Short Interest Amarin Short Interest Black Diamond Therapeutics Short Interest Erasca Short Interest Mereo BioPharma Group Short Interest Ocugen Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:HARP) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupUrgent Nvidia WarningAltimetry